MENU

ALLO Allogene Therapeutics Forecast, Technical & Fundamental Analysis

Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases... Show more

Industry: #Biotechnology
ALLO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
ALLO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ALLO is expected to report earnings to -12 cents per share on November 05

Allogene Therapeutics ALLO Stock Earnings Reports
Q3'26
Est.
$-0.13
Q2'26
Beat
by $0.04
Q1'26
Beat
by $0.01
Q4'25
Beat
by $0.06
Q3'25
Beat
by $0.03
The last earnings report on August 12 showed earnings per share of -12 cents, beating the estimate of -17 cents. With 5.00M shares outstanding, the current market capitalization sits at 459.50M.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RNTX0.620.03
+4.99%
Rein Therapeutics Inc
ADUR10.370.24
+2.37%
Aduro Clean Technologies Inc
VMI448.48-2.20
-0.49%
Valmont Industries
SPB78.96-0.60
-0.75%
Spectrum Brands Holdings
MBINL23.25-0.21
-0.90%
Merchants Bancorp

ALLO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLO has been loosely correlated with EDIT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ALLO jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLO
1D Price
Change %
ALLO100%
N/A
EDIT - ALLO
46%
Loosely correlated
-2.71%
RCKT - ALLO
45%
Loosely correlated
-5.98%
AXON - ALLO
44%
Loosely correlated
+2.54%
ARRY - ALLO
43%
Loosely correlated
+2.40%
FDMT - ALLO
42%
Loosely correlated
-3.66%
More
A.I. Advisor
published General Information

General Information

a developer of allogeneic chimeric antigen receptor therapy

Industry Biotechnology

Industry
Biotechnology
Address
210 East Grand Avenue
Phone
+1 650 457-2700
Employees
152
Web
https://www.allogene.com
Allogene Therapeutics (ALLO) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com